Prevalence of Therapeutic Non-Adherence in Type 2 Diabetic Patients at the Maradi Reference Hospital

<div> <div> <div> <div> <p>Introduction: Type 2 diabetes (T2D) represents a major public health problem. Monitoring and control are hampered by the issue of therapeutic non-adherence. The objective of this work was to evaluate the level of therapeutic adherence in type 2 diabetic patients. Methodology. This was a descriptive, cross-sectional study involving type 2 diabetic patients followed as outpatients. Sociodemographic variables, those related to therapeutic adherence, and factors that could influence therapeutic adherence were collected and analyzed. Adherence was assessed using the Morisky questionnaire (also called MMAS for Morisky Medication Adherence Scale). The results were analyzed using SPSS software version 27.0.1. Results: We recorded 108 patients meeting our inclusion criteria. The mean age was 51.09 years with extremes ranging from 14 to 74 years. The 30 to 60-year- old age group was the most represented at 70.4%. The study population was predominantly female in 63.9% of cases, with a sex ratio of 0.56. Patients with secondary and higher education levels were the most represented at 38% each, and 55.6% of patients reported receiving family support. The majority of patients (66.7%) were treated with oral antidiabetic drugs alone. The consultation frequency was monthly in 48.1% of cases. The proportion of non-adherent patients is high (67.6%). Conclusion: Therapeutic adherence among type 2 diabetic patients at the Maradi Reference Hospital is low.</p> </div> </div> </div> </div>

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-14
DOI
https://doi.org/10.59324/ejmhr.2025.3(6).41
Primary Topic
Medication Adherence and Compliance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Therapeutic Non-Adherence in Type 2 Diabetic Patients at the Maradi Reference Hospital

Mamane Barga A, Mbaye Salissou S. M., Liman Elhadji Ali I.T., Abdoulaye O. et al.
Zenodo (CERN European Organization for Nuclear Research)
Medication Adherence and Compliance
article

Prevalence of Therapeutic Non-Adherence in Type 2 Diabetic Patients at the Maradi Reference Hospital

Mamane Barga A, Mbaye Salissou S. M., Liman Elhadji Ali I.T., Abdoulaye O., Douka A., Harouna Malam Brah N. A., Mahamane Sani M. A., Laouan H., Oudou Mossi Maiga M., Adehossi E. O., Aboubakar Saidou A. A.
article en

Abstract

<div> <div> <div> <div> <p>Introduction: Type 2 diabetes (T2D) represents a major public health problem. Monitoring and control are hampered by the issue of therapeutic non-adherence. The objective of this work was to evaluate the level of therapeutic adherence in type 2 diabetic patients. Methodology. This was a descriptive, cross-sectional study involving type 2 diabetic patients followed as outpatients. Sociodemographic variables, those related to therapeutic adherence, and factors that could influence therapeutic adherence were collected and analyzed. Adherence was assessed using the Morisky questionnaire (also called MMAS for Morisky Medication Adherence Scale). The results were analyzed using SPSS software version 27.0.1. Results: We recorded 108 patients meeting our inclusion criteria. The mean age was 51.09 years with extremes ranging from 14 to 74 years. The 30 to 60-year- old age group was the most represented at 70.4%. The study population was predominantly female in 63.9% of cases, with a sex ratio of 0.56. Patients with secondary and higher education levels were the most represented at 38% each, and 55.6% of patients reported receiving family support. The majority of patients (66.7%) were treated with oral antidiabetic drugs alone. The consultation frequency was monthly in 48.1% of cases. The proportion of non-adherent patients is high (67.6%). Conclusion: Therapeutic adherence among type 2 diabetic patients at the Maradi Reference Hospital is low.</p> </div> </div> </div> </div>

Zenodo (CERN European Organization for Nuclear Research)
Reduced inequalities
Openalex Percentile: Top 79%
Medication Adherence and Compliance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prevalence of Therapeutic Non-Adherence in Type 2 Diabetic Patients at the Maradi Reference Hospital — Mamane Barga A, Mbaye Salissou S. M., et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS